The pace of entry of medical device products into ordinary households will be greatly accelerated

China has now entered an era of aging population. As of the end of last year, China’s elderly population over 60 years old has reached 160 million. Guo Fanli, a researcher in the pharmaceutical industry of China Investment Consulting, pointed out that because the elderly need long-term medical care and people’s health care Demand is increasing, so the pace of future medical device products entering ordinary families in China will be greatly accelerated.

Guo Fanli, a researcher in the pharmaceutical industry of China Investment Consulting, pointed out that there are three main reasons for the acceleration of the entry of medical device products into ordinary families. The first one is the expansion of the medical device market in China since the new medical reform. The new medical reform has increased the number of grassroots medical institutions in China. Investing in medical device products will also benefit significantly, which is a prerequisite for medical device products to enter the ordinary family.

Guo Fanli pointed out that, secondly, today's medical devices are no longer as complex and difficult to master as large medical devices in the past. Now with the advancement of technology, these medical devices are gradually becoming electronic, miniaturized and intelligent. Development, its use is also simpler and more convenient, easy to be mastered by ordinary consumers, which is also an indispensable condition.

Guo Fanli also pointed out that in the end, the pace of entry of medical device products into ordinary households has benefited from the improvement of people's living standards in recent years. In addition, medical device products have gradually separated from traditional sales channels such as pharmacies and supermarkets and turned to professional chain stores. It is also more convenient for people to purchase medical devices, and the increase in consumer awareness has also led to the entry of medical devices into the home.

According to the "2009-2012 China Medical Device Industry Investment Analysis and Prospect Forecast Report" issued by China Investment Consulting, in 2008, the market share of China's home medical devices reached more than 8 billion yuan, an increase of nearly 30% over the previous year. With the steady implementation of the new medical reform, the medical device market has also shown an accelerated growth trend, and the pace of entering the ordinary family has also greatly accelerated.

[Composition]

The main component of this preparation is human immunoglobulin, which is prepared by cold ethanol fractionation of human plasma from healthy donors. The manufacturing process contains a step to remove anticomplementary activity and a dual viral inactivation process. It contains a suitable amount of glucose or maltose as stabilizer (see table below), but does not contain any antiseptic or antibiotic. The distribution of IgG subclasses is close to the serum level of normal subjects and maintains the bioactivity of Fc fragment of IgG.

[Indications]

1. Primary agammaglobulinemia, such as X-linked hypogammaglobulinemia, common variant immunodeficiency diseases, immunoglobulin G subclass deficiency, etc.

2. Secondary immunoglobulin deficiency diseases, such as severe infection, septicemia of newborn, etc

3. Autoimmune diseases, such as primary thrombocytopenic purpura, Kawasaki disease

Intravenous Injection Of Human Immunoglobulin

Intravenous Injection Of Human Immunoglobulin,Intravenous Immunoglobulin,High-Quality Effective Intravenous Immunoglobulin,Human Immunoglobulin For Intravenous Injection

Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. , https://www.syimmunoglobulin.com

Posted on